Lactobacillus is one of the bacteria strains which has been widely used in human life, has valuable probiotic properties. In the present study, L. reuteri FLRE5K1 was isolated from healthy mouse kidney and tested for its anti-melanoma activity in cell assays and animal models. The results showed that L. reuteri FLRE5K1 could significantly reduce the incidence of melanoma from 70 % to 30 % and significantly prolonged the survival of tumor-bearing mice. Despite of its significant effect on melanoma prevention, the tumor mass remained uneliminated. The alanine aminotransferase (ALT) level remained normal in tumor-bearing mice with intragastric administration of L. reuteri FLRE5K1, indicating that L. reuteri FLRE5K1 could prevent melanoma cells from damaging the liver. Cell assays showed that melanoma cells were inhibited by serum from mice with intragastric administration of L. reuteri FLRE5K1, but not by the bacteria itself. Further examination revealed that the levels of TNF-α and INF-γ in this serum were significantly increased. In summary, it was speculated that L. reuteri FLRE5K1 could stimulate the body to produce anti-cancer cytokines, inhibit the migration and colonization of melanoma cell line B16-F10, so as to prevent the onset of melanoma and prolong the survival of mice. The experiment was a useful complement to functional studies of endogenous probiotics and provided theoretical data support for the development of new microbioecologics.Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
August 24, 2020
May 12, 2020
Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients.
December 10, 2020
- AACR-2020The American Association for Cancer Research is the world's oldest and largest professional association related to cancer research.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.